Simplicon^® Human iPS Cell Line

The discovery that somatic cells could revert back to pluripotent like cells in 2006 by Shinya Yamanaka created an entirely new area of stem cell biology. Human iPS cells removed the ethical concerns associated with embryonic stem cells and allowed scientists to model human diseases that were previously impossible to model such as Alzheimer′s, Parkinson′s and Autism. Human induced pluripotent stem cells (iPSCs), have the capacity to give rise to differentiated progeny representative of all three germ layers (ectoderm, endoderm, and mesoderm). The ability to expand pluripotent cells in vitro and subject them to direct differentiation to produce specific cell types is crucial for the development of potential cell-based therapies and disease-in-a-dish cell models for research.

Simplicon^® RNA Reprogramming Technology is a next generation non-integrating reprogramming system that uses a single synthetic self-replicating RNA strand engineered to mimic cellular RNA to generate human iPS cells. The single RNA strand contains the four reprogramming factors, OCT-4, KLF-4, SOX-2 and GLIS1 (OKSG) and enables extremely efficient reprogramming using a single transfection step without any viral intermediates or host genome integration. TheSimplicon^® human iPS cell line was generated by reprogramming human foreskin fibrobalsts (SCC058) using theSimplicon^® RNA Reprogramming Kit (SCR550). The cell line is integration-free, highly characterized and maintains a pluripotent phenotype over multiple passages.

Highly characterized integration-free human induced pluripotent stem cell (iPSC) line generated using Simplicon^® RNA reprogramming technology.

≥1X10⁶ cells/vial

>=1X10⁶ cells/vial

Simplicon^® human iPS cells should be stored in liquid nitrogen. The cells can be cultured for at least 10 passages after initial thawing without significantly affecting the cell marker expression and functionality.

This product is intended for sale and sold solely to academic institutions for internal academic research use per the terms of the “Academic Use Agreement” as detailed in the product documentation. For information regarding any other use, please contact licensing@emdmillipore.com.

SIMPLICON is a registered trademark of Merck KGaA, Darmstadt, Germany

RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.